[SLRX] YoY Quarter Result on 30-Sep-2015 [#Q3]

Stock
[SLRX] Salarius Pharmaceuticals, Inc.
Announcement Date
04-Nov-2015
Financial Year
2015
Quarter
30-Sep-2015 [#Q3]
Profit Trend
QoQ- -15.19%
YoY- -310.52%
Quarter Report
SLRX's Result
SLRX's Financial Summary
View:
Show?
Quarter Result
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
Revenue 1,378 875 251 414 599 0 0 -
PBT -1,717 -2,630 -2,638 -9,332 -10,637 -8,153 -1,986 -2.39%
Tax -42 -2 0 0 0 0 0 -
NP -1,717 -2,628 -2,638 -9,332 -10,637 -8,153 -1,986 -2.39%
Tax Rate - - - - - - - -
Total Cost 3,095 3,503 2,889 9,746 11,237 8,153 1,986 7.66%
Ratio Analysis
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
NP Margin -124.55 -300.33 -1,051.18 -2,256.31 -1,775.66 0.00 0.00 -
Per Share
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
EPS -2.39 -18.22 -91.27 -335.48 -406.35 -333.26 -219.74 -52.89%
EPS Diluted -2.39 -18.22 -91.27 -335.48 -406.35 -333.26 -219.74 -52.89%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.